Mettler-Toledo International (NYSE:MTD – Get Free Report) had its target price raised by stock analysts at Wells Fargo & Company from $1,350.00 to $1,400.00 in a report issued on Monday,Benzinga reports. The firm currently has an “equal weight” rating on the medical instruments supplier’s stock. Wells Fargo & Company‘s price objective points to a potential upside of 1.94% from the company’s previous close.
A number of other equities analysts have also recently issued reports on MTD. Wolfe Research began coverage on Mettler-Toledo International in a report on Friday, December 13th. They issued a “peer perform” rating for the company. Citigroup raised Mettler-Toledo International from a “sell” rating to a “neutral” rating and upped their target price for the stock from $1,200.00 to $1,300.00 in a research note on Wednesday, December 11th. Robert W. Baird lifted their price target on shares of Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the stock a “neutral” rating in a research note on Monday. Evercore ISI raised shares of Mettler-Toledo International from an “in-line” rating to an “outperform” rating and upped their price objective for the company from $1,375.00 to $1,450.00 in a research note on Thursday, January 2nd. Finally, Stifel Nicolaus decreased their target price on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating on the stock in a research report on Monday, November 11th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $1,364.88.
View Our Latest Stock Report on Mettler-Toledo International
Mettler-Toledo International Trading Up 1.2 %
Mettler-Toledo International (NYSE:MTD – Get Free Report) last issued its quarterly earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 EPS for the quarter, topping analysts’ consensus estimates of $11.76 by $0.65. Mettler-Toledo International had a net margin of 22.29% and a negative return on equity of 564.51%. Research analysts forecast that Mettler-Toledo International will post 41.94 earnings per share for the current year.
Insiders Place Their Bets
In other news, insider Gerry Keller sold 140 shares of the business’s stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $1,254.09, for a total transaction of $175,572.60. Following the transaction, the insider now directly owns 6 shares of the company’s stock, valued at approximately $7,524.54. The trade was a 95.89 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.94% of the company’s stock.
Institutional Inflows and Outflows
Several institutional investors have recently added to or reduced their stakes in MTD. Sanctuary Advisors LLC purchased a new position in shares of Mettler-Toledo International during the second quarter valued at about $500,000. Wedmont Private Capital bought a new position in shares of Mettler-Toledo International in the 3rd quarter worth approximately $246,000. Livforsakringsbolaget Skandia Omsesidigt lifted its stake in shares of Mettler-Toledo International by 400.0% in the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 125 shares of the medical instruments supplier’s stock valued at $187,000 after purchasing an additional 100 shares during the period. Exchange Traded Concepts LLC boosted its position in shares of Mettler-Toledo International by 2,300.0% during the third quarter. Exchange Traded Concepts LLC now owns 144 shares of the medical instruments supplier’s stock valued at $216,000 after purchasing an additional 138 shares in the last quarter. Finally, Koshinski Asset Management Inc. raised its holdings in Mettler-Toledo International by 40.0% in the third quarter. Koshinski Asset Management Inc. now owns 322 shares of the medical instruments supplier’s stock worth $483,000 after purchasing an additional 92 shares in the last quarter. 95.07% of the stock is currently owned by institutional investors.
Mettler-Toledo International Company Profile
Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.
Featured Articles
- Five stocks we like better than Mettler-Toledo International
- The 3 Best Blue-Chip Stocks to Buy Now
- 3 Reasons to Love This Underperforming Chipmaker
- What Are Growth Stocks and Investing in Them
- These Stocks Missed on Earnings, But Will Rebound Next Quarter
- Roth IRA Calculator: Calculate Your Potential Returns
- With Policy Shifts in Play, Are Crypto Stocks Worth Another Look?
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.